Literature DB >> 9185524

Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.

M Kochetkova1, P O Iversen, A F Lopez, M F Shannon.   

Abstract

Juvenile myelomonocytic leukemia (JMML) is a severe childhood malignancy. The autocrine production of GMCSF is believed to be responsible for the spontaneous proliferation of JMML cells. A nuclear factor-kappaB (NF-kappaB)/Rel binding site within the GM-CSF gene promoter, termed the kappaB element, plays an important role in controlling transcription from the GM-CSF gene. We investigated the effect of an oligonucleotide GM3, directed to form a DNA triple helix across this kappaB element, on growth and GM-CSF production by JMML cells. Treatment of these cells, either unstimulated or induced by TNFalpha, with GM3 led to a significant and specific inhibition of both GM-CSF production and spontaneous colony formation. This constitutes the first report linking specific triplex-mediated inhibition of gene transcription with a functional outcome; i.e., cell growth. We observed the constitutive presence of NF-kappaB/Rel proteins in the nucleus of JMML cells. The constitutive and TNFalpha-induced NF-kappaB/Rel complexes were identical and were composed mainly of p50 and c-Rel proteins. Treatment of the cells with a neutralizing anti-TNFalpha monoclonal antibody completely abrogated constitutive nuclear expression of NF-kappaB/Rel proteins. These results indicate that the aberrant, constitutive GM-CSF gene activation in JMML is maintained by TNFalpha-mediated activation of NF-kappaB/Rel proteins. Our findings identify the molecular basis for the autocrine TNFalpha activation of the GM-CSF gene in JMML and suggest potential novel and specific approaches for the treatment of this aggressive childhood leukemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185524      PMCID: PMC508152          DOI: 10.1172/JCI119495

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia.

Authors:  H S Chan; Z Estrov; S S Weitzman; M H Freedman
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

2.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

3.  Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro.

Authors:  M Cooney; G Czernuszewicz; E H Postel; S J Flint; M E Hogan
Journal:  Science       Date:  1988-07-22       Impact factor: 47.728

4.  Sequence-specific cleavage of double helical DNA by triple helix formation.

Authors:  H E Moser; P B Dervan
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

5.  Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia.

Authors:  R J Gualtieri; P D Emanuel; K S Zuckerman; G Martin; S C Clark; R K Shadduck; R A Dracker; J Akabutu; R Nitschke; M L Hetherington
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

6.  Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10.

Authors:  C Y Brown; C A Lagnado; M A Vadas; G J Goodall
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

7.  Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors.

Authors:  H Castro-Malaspina; G Schaison; S Passe; A Pasquier; R Berger; C Bayle-Weisgerber; D Miller; M Seligmann; J Bernard
Journal:  Cancer       Date:  1984-08-15       Impact factor: 6.860

8.  Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia.

Authors:  J E Sanders; C D Buckner; E D Thomas; R Fleischer; K M Sullivan; F A Appelbaum; R Storb
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

9.  Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage.

Authors:  R A Lang; D Metcalf; R A Cuthbertson; I Lyons; E Stanley; A Kelso; G Kannourakis; D J Williamson; G K Klintworth; T J Gonda
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

10.  Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.

Authors:  W D Xu; G S Firestein; R Taetle; K Kaushansky; N J Zvaifler
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

View more
  10 in total

1.  Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells.

Authors:  C Shen; A Buck; G Mehrke; B Polat; H Gross; M Bachem; S Reske
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

Review 2.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

3.  Oleandrin-mediated expression of Fas potentiates apoptosis in tumor cells.

Authors:  Yashin Sreenivasan; Pongali B Raghavendra; Sunil K Manna
Journal:  J Clin Immunol       Date:  2006-06-16       Impact factor: 8.317

4.  Blocking transcription of the human rhodopsin gene by triplex-mediated DNA photocrosslinking.

Authors:  Z Intody; B D Perkins; J H Wilson; T G Wensel
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

5.  Detection and determination of oligonucleotide triplex formation-mediated transcription-coupled DNA repair in HeLa nuclear extracts.

Authors:  G Wang; Z Chen; S Zhang; G L Wilson; K Jing
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

6.  AKT Isoforms in the Immune Response in Cancer.

Authors:  Zayd Ahmad; Payaningal R Somanath
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 7.  The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.

Authors:  Timothy R Hercus; Daniel Thomas; Mark A Guthridge; Paul G Ekert; Jack King-Scott; Michael W Parker; Angel F Lopez
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

8.  Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins.

Authors:  Adele F Holloway; Sudha Rao; Xinxin Chen; M Frances Shannon
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

Review 9.  The triple helix: 50 years later, the outcome.

Authors:  Maria Duca; Pierre Vekhoff; Kahina Oussedik; Ludovic Halby; Paola B Arimondo
Journal:  Nucleic Acids Res       Date:  2008-08-01       Impact factor: 16.971

10.  Nuclear Nox4-derived reactive oxygen species in myelodysplastic syndromes.

Authors:  Marianna Guida; Tullia Maraldi; Francesca Beretti; Matilde Y Follo; Lucia Manzoli; Anto De Pol
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.